Canagliflozin vs Empagliflozin
Canagliflozin vs Empagliflozin: Overview
This comparison examines the pharmacological differences between Canagliflozin and Empagliflozin.
Mechanism of Action
Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.
Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.
Pharmacokinetics
Half-life: Canagliflozin β 10.6 hours; Empagliflozin β 12.4 hours.
Chemical Properties
Molecular Formula: Canagliflozin β C24H25FO5S; Empagliflozin β C23H27ClO7.
Molecular Weight: Canagliflozin β 444.5170 g/mol; Empagliflozin β 450.9100 g/mol.
Type: Canagliflozin β Small molecule; Empagliflozin β Small molecule.